Articles On Telix Pharmaceuticals (ASX:TLX)

Telix Pharmaceuticals' prostate cancer imaging product Illucix is quickly conquering the USA, but management at the firm has (much) higher ambitions. ASX Code: ((TLX)) Market cap: $2.02bn Shares on issue: 312,916,341 Chief executive officer...

A busy week of corporate earnings faces a rocky start after Wall Street’s four-week winning run ended as traders grew more cautious about the outlook for interest rates. ASX futures declined 29 points or 0.41 per cent. The S&P/ASX 20...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX Powerplays. ASX health sector modestly up...

ShareCafeEvening Report: 18 August, 2022 by Paul Sanger   At the closing bell, the S&P/ASX 200 was 0.21 per cent or 14.90 points lower at 7112.80. The Dow Jones futures are pointing to a fall of 58 points. The S&P 500 futures are po...

The share market suffered its first setback in four sessions following weak US leads and as “messy” jobs data muddied the outlook for interest rates. The S&P/ASX 200 declined 15 points or 0.21 per cent from yesterday’s ten-week closi...

The ASX 200 finished lower today Xero dragged down Tech sector  Australia’s jobless rate is at 3.4% lowest in almost half a century   The ASX 200 index fell for the first time this week, down by 0.30%, as Tech stocks dragged the bourse lo...

The share market fell for the first time in four sessions following weak leads from Wall Street, declines in key commodities and earnings misses from Origin Energy and Transurban. The S&P/ASX 200 declined 22 points or 0.31 per cent t...

Respiri gives update on US market Screening results from 19 of Emyria’s MDMA compounds have been returned Telix reports strong half-year results Respiratory disease specialist, Respiri (ASX:RSH), surged 14% this morning after updating the...

The Telix Pharmaceuticals Ltd (ASX: TLX) share price plunged in early trade on Thursday after the company revealed its results for the half-year ending 30 June. Shares in the ASX biotech company are currently trading down 4.1% at $6.96 aft...

Aussie stocks were poised to open lower following a volatile session in the US as investors assessed mixed earnings from retailers and the likelihood of another jumbo interest rate hike next month. The Dow’s five-session win streak ended...

Recent cap raising suggests biotechs may finally be making a comeback Mesblast annnounced a US$45m cap raise last week Today, Paradigm, Opthea, and Proteomics also announced fund raises Over the past year, the biotech sector has been caug...

ShareCafeLunch Report: 12 August, 2022 by Paul Sanger   At noon, the S&P/ASX 200 is 0.42 per cent or 29.50 points lower at 7041.50. The SPI futures are pointing to a fall of 32 points. Best and worst performers The best-performing secto...

JPMorgan’s equities desk is seeking buyers about a 3 per cent stake in ASX-listed Telix Pharmaceuticals on Thursday evening. 

Telix (ASX:TLX) has announced that it has been jointly awarded a $4.8 million Australian Research Council grant to establish a new Industrial Transformation Research Program Hub as part of a consortium of applicants led by The Unive...

MELBOURNE, Australia, Aug. 8, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has been jointly awarded a $4.8 million Australian Research Council (ARC) grant to establish a new Ind...

The Telix Pharmaceuticals Ltd (ASX: TLX) share price finished the session on Friday up 0.52% to $7.79. Over the past month, the ASX healthcare share has risen in value by an extraordinary 50.1%. Contributing to this gain was the investor...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX Powerplays. Morgans takes conservative app...

ShareCafeGlobal Biotech Turnaround Looks to Be Underway Signs of life are emerging in the global biotech sector, after the longest and sharpest downturn in history that was so severe it left hundreds US companies trading below cash backing....

The S&P/ASX 200 Index (ASX: XJO) slipped ever so slightly on Thursday after major commodity prices tumbled overnight. The index was 0.01% lower at 6,974.90 points as of the market’s close. The slip came despite a decent performance b...

The ASX 200 finished little changed after failing to sustain a push above 7000. The Australian benchmark hit a seven-week high of 7021 in the first half hour before a session-long fade stripped its gains. The index finished a single poin...

The S&P/ASX 200 traded briefly above 7000 after oil fell to a six-month low and upbeat US economic data soothed global recession worries. The Australian benchmark touched a seven-week high of 7021 before shaving its advance to 12 poi...

The S&P/ASX 200 Index (ASX: XJO) defied its earlier downturn to close higher after the Reserve Bank of Australia (RBA) lifted interest rates for a fourth consecutive month. The index was 0.07% higher at 6,998.10 points at Tuesday’s c...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) has fought back and is edging slightly higher. At the time of writing, the benchmark index is up to 6,994.9 points. Four ASX shares that are climbing more than most today are listed...

ShareCafeLunch Report: 2 August, 2022 by Paul Sanger   The Reserve Bank of Australia is expected to hike by 50 basis points after official data showed prices in Australia rose 6.1 per cent in the second quarter compared with a year ago. At...

MELBOURNE, Australia, Aug. 2, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today reports on regulatory progress for the Company’s core prostate and kidney cancer imaging programs in the Asia Pacific (A...

Highlights:  WHO has declared Monkeypox a global health emergency as cases have surfaced in 74 countries sofar. In Australia, so far, 44 confirmed cases of Monkeypox have been confirmed. Monkeypox is a disease that causes rash turning...

Highlights:  WHO has declared Monkeypox a global health emergency as cases have surfaced in 74 countries sofar. In Australia, so far, 44 confirmed cases of Monkeypox have been confirmed. Monkeypox is a disease that causes rash turning...

In times of great uncertainty the Australian healthcare sector can offer investors plenty of choice, with varying degrees of risk and opportunities. -Australia’s healthcare sector has seen record government investment-Global pandemic has ac...

After a wobbly start to the day, the S&P/ASX 200 Index (ASX: XJO) posted a gain for the first time in three sessions after lacklustre performances yesterday and on Friday. At the end of Tuesday’s trade, the index was up 0.26% at 6,...

The share market logged its best week since March as a six-week high on Wall Street bolstered confidence this year’s market rout may be easing.   The S&P/ASX 200 eased three points or 0.04 per cent today, falling narrowly short of a...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a small gain. At the time of writing, the benchmark index is up 0.1% to 6,800.9 points. Four ASX shares that are climbing more than most today are listed bel...

ShareCafeLunch Report: 22 July, 2022 by Paul Sanger   The S&P/ASX 200 traded flat by midday in Sydney after spending much of the morning in negative territory. The benchmark erased early losses after opening 0.5 per cent lower and brief...

Australian shares gained momentum late morning, rising for a third session despite weak earnings from social media giant Snap weighing on US futures. The S&P/ASX 200 overcame early weakness to reach the halfway mark 16 points or 0.24...

ShareCafeEvening Report: 21 July, 2022 by Paul Sanger   At the closing bell, the S&P/ASX 200 was 0.52 per cent or 35.10 points higher at 6794.30. The lithium and green metals sector was on fire today, after electric vehicle maker Tesla...

ASX closes 0.30% higher after being in the red Lithium stocks rise on Tesla guidance Woodside down despite bumper revenue After trading in red for most of the day, the ASX 200 finished Thursday 0.40 higher at 6,784. Energy stocks dragged...

A late rally lifted the Australian share market to its strongest close in five weeks as strength in bank and tech stocks outweighed pressure on iron ore miners after China established a steelmakers’ purchasing cartel. The S&P/ASX 200...

Melbourne-based Telix Pharmaceuticals says it made $19.3m in just 10 weeks after beginning US sales of its new prostate cancer diagnostic imaging agent.

Telix Pharmaceuticals (TLX) reports more than a ten-fold quarter-on-quarter revenue increase for the three months ending June 30 The healthcare company received $22.5 million in total revenue which reflects sales of its prostate cancer ima...

The share market hovered near a three-week high as declines in resource stocks outweighed gains in growth sectors. The S&P/ASX 200 eased five points or 0.07 per cent by lunchtime. The Australian benchmark struggled for direction afte...

ShareCafeLunch Report: 21 July, 2022 by Paul Sanger   Australian shares are little changed in mixed trading this morning. At noon, the S&P/ASX 200 is 0.05 per cent or 3.60 points lower at 6755.60. Australian lithium and nickel companies...

ShareCafeStocks of the Hour: 21 July, 2022                  Orthocell (ASX:OCC) recently signed a global exclusive licence and distribution agreement with BioHorizons Implant Systems Inc, one of the largest dental implant companies in...

At lunch on Thursday, the S&P/ASX 200 Index (ASX: XJO) is on course to record a small decline. The benchmark index is currently down 0.1% to 6,754.1 points. Here’s what is happening on the ASX 200 today: ANZ shares edge lower The Au...

21 Jul 2022 - A snapshot of the stocks on the move featuring Orthocell (ASX:OCC), Telix Pharmaceuticals (ASX:TLX) and Asra Minerals (ASX:ASR).

The Telix Pharmaceuticals Ltd (ASX: TLX) share price is pushing higher in trade today. At the time of writing, the share is trading more than 11% in the green at $6.21 apiece. Investors are bidding up the Telix share price following t...

Highlights: ASX 200 stocks opened a little lower today, however, the benchmark index recovered a bit and started trading flat after a while. The market has been taking cues from the Wall Street that ended lower in its last session thou...

MELBOURNE, Australia, July 21, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today issues its Appendix 4C quarterly cash flow statement and accompanying Activities Report for the quarter ended 30 June 2...

Mach 7 announces patent infringement lawsuit settled in its favour Lumos Diagnostics tanks after device submission for FebriDX rejected by US FDA Three companies announce major milestones in clinical trials Healthcare and life sciences e...

“Your Stock Request” is a weekly video where we analyse share price charts for stocks on the Australian market (ASX) as requested by you! Email us at [email protected] with your stock request. Limit of one per person, no guarantee o...

ASX biotech shares were hammered in FY22 with the sector facing heavy losses, in line with the wider technology sector. The ETFs S&P Biotech ETF (ASX: CURE), an index fund tracking the global biotech sector, is down almost 24% this y...

Telix Pharmaceuticals (ASX:TLX) has announced the appointment of a CEO for its Americas business and dosed the final patient and completed recruitment into the pivotal Phase 3 study, ZIRCON.